Literature DB >> 15934047

Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?

Haralabos Zorbas1, Bernhard K Keppler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15934047     DOI： 10.1002/cbic.200400427

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  21 in total

1.  Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Authors:  Johnny Moretto; Bruno Chauffert; François Ghiringhelli; Janice R Aldrich-Wright; Florence Bouyer
Journal:  Invest New Drugs       Date:  2010-06-10       Impact factor: 3.850

2.  Kinetics and mechanism of the substitution reactions of [PtCl(bpma)]+, [PtCl(gly-met-S,N,N)] and their aqua analogues with L-methionine, glutathione and 5'-GMP.

Authors:  Zivadin D Bugarcić; Jovana Rosić; Biljana Petrović; Nadine Summa; Raph Puchta; Rudi van Eldik
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

3.  Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.

Authors:  Cara A Rabik; Melissa L Fishel; Julianne L Holleran; Kristen Kasza; Mark R Kelley; Merrill J Egorin; M Eileen Dolan
Journal:  J Pharmacol Exp Ther       Date:  2008-07-29       Impact factor: 4.030

4.  Role of copper transporters in resistance to platinating agents.

Authors:  Cara A Rabik; Edward B Maryon; Kristen Kasza; John T Shafer; Catherine M Bartnik; M Eileen Dolan
Journal:  Cancer Chemother Pharmacol       Date:  2008-11-08       Impact factor: 3.333

5.  Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.

Authors:  Xifeng Wu; Charles Lu; Yuanqing Ye; Joe Chang; Hushan Yang; Jie Lin; Jian Gu; Waun Ki Hong; David Stewart; Margaret R Spitz
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

6.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

7.  Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.

Authors:  K R Fareed; A Al-Attar; I N Soomro; P V Kaye; J Patel; D N Lobo; S L Parsons; S Madhusudan
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

8.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

9.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

10.  DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus.

Authors:  Laura Baranello; Davide Bertozzi; Maria Vittoria Fogli; Yves Pommier; Giovanni Capranico
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.